Prenatal Hemophilia A Common Mutation Screening Factor VIII Intron 22 and Intron 1 Inversion Analysis
Introduction
Prenatal Hemophilia A Common Mutation Screening is a vital genetic test for expectant parents. This screening focuses on identifying specific mutations in the Factor VIII gene, particularly Intron 22 and Intron 1 inversions. Understanding these mutations is crucial for assessing the risk of Hemophilia A in the unborn child, allowing families to make informed decisions regarding their pregnancy and childbirth.
What the Test Measures
This test detects mutations in the Factor VIII gene, which are responsible for Hemophilia A. By analyzing the presence of Intron 22 and Intron 1 inversions, healthcare providers can determine the likelihood of the child inheriting this bleeding disorder.
Who Should Consider This Test
Expectant parents should consider this test if:
- There is a family history of Hemophilia or bleeding disorders.
- The mother is a known carrier of the Hemophilia gene.
- There are symptoms of bleeding disorders in the family.
Benefits of Taking the Test
Taking the Prenatal Hemophilia A Common Mutation Screening offers several benefits:
- Early identification of genetic risks associated with Hemophilia A.
- Informed decision-making regarding pregnancy management and delivery options.
- Peace of mind for parents regarding their child’s health.
Understanding Your Results
Results from the Prenatal Hemophilia A Common Mutation Screening will indicate whether the specific mutations are present. A healthcare provider will guide you through the results, explaining their implications for your pregnancy and the potential need for further testing or monitoring.
Test Pricing
| Price Type | Price (KSh) |
|---|---|
| Discount Price | 30,000 |
| Regular Price | 40,000 |
Test Details
Turnaround Time: 10-11 days
Sample Type: Peripheral blood / Amniotic Fluid / Chorionic villi / Cord blood
Test Components: Sterile container / Sterile Normal Saline Container / EDTA Vacutainer (2ml)
Pre-Test Instructions: Prenatal Hemophilia A Common Mutation Screening requires a Doctor’s prescription. Note that this is not applicable for surgery and pregnancy cases or individuals planning to travel abroad.
Branches and Booking
We have branches across Kenya and offer home sample collection services for your convenience. Book your Prenatal Hemophilia A Common Mutation Screening today by calling or WhatsApping us at +254711564616!
